| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
250,492 |
229,555 |
$85.51M |
| 0510 |
|
170,772 |
159,668 |
$13.95M |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,548 |
1,360 |
$299K |
| 0513 |
Prolong prev svcs, addl 30m |
3,727 |
3,479 |
$291K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
4,286 |
645 |
$119K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
9,738 |
3,214 |
$110K |
| 0002A |
|
7,817 |
4,817 |
$80K |
| 0001A |
|
6,334 |
4,023 |
$66K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,112 |
477 |
$46K |
| 96152 |
|
911 |
221 |
$36K |
| 90791 |
Psychiatric diagnostic evaluation |
1,391 |
456 |
$35K |
| 96158 |
|
936 |
168 |
$20K |
| 0004A |
|
354 |
354 |
$14K |
| 0054A |
|
265 |
257 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
185,786 |
114,329 |
$9K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,821 |
3,720 |
$9K |
| 90863 |
|
668 |
194 |
$5K |
| 0124A |
|
123 |
111 |
$4K |
| 0012A |
|
618 |
367 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,702 |
19,101 |
$4K |
| 0064A |
|
86 |
86 |
$3K |
| 0011A |
|
543 |
311 |
$3K |
| 0071A |
|
69 |
69 |
$3K |
| 99078 |
|
31 |
25 |
$3K |
| Z7500 |
|
113,660 |
107,507 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,621 |
619 |
$2K |
| 90834 |
Psychotherapy, 45 minutes with patient |
44 |
13 |
$2K |
| 0003A |
|
19 |
19 |
$760.00 |
| 91322 |
|
153 |
93 |
$650.00 |
| 0052A |
|
14 |
14 |
$560.00 |
| 96153 |
|
918 |
221 |
$410.20 |
| 90480 |
|
212 |
126 |
$200.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
9,823 |
5,915 |
$164.08 |
| Q3014 |
Telehealth originating site facility fee |
125,480 |
68,392 |
$83.60 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
720 |
416 |
$51.31 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
25,278 |
16,717 |
$29.00 |
| 90686 |
|
12,681 |
5,799 |
$0.00 |
| 93018 |
|
1,126 |
1,125 |
$0.00 |
| 93351 |
|
1,926 |
964 |
$0.00 |
| 88720 |
|
2,302 |
1,604 |
$0.00 |
| 84132 |
|
129 |
83 |
$0.00 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,620 |
4,304 |
$0.00 |
| 90656 |
|
2,814 |
1,208 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
7,460 |
4,711 |
$0.00 |
| Z1034 |
|
1,837 |
1,199 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
2,090 |
1,340 |
$0.00 |
| 90647 |
|
320 |
153 |
$0.00 |
| Z7610 |
|
1,420 |
1,268 |
$0.00 |
| 90697 |
|
457 |
265 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,123 |
715 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,256 |
1,409 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
427 |
263 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
929 |
547 |
$0.00 |
| 90739 |
|
719 |
493 |
$0.00 |
| 82607 |
|
804 |
529 |
$0.00 |
| 85027 |
|
598 |
367 |
$0.00 |
| 90680 |
|
792 |
289 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
356 |
236 |
$0.00 |
| 90677 |
|
710 |
425 |
$0.00 |
| 93016 |
|
1,126 |
1,125 |
$0.00 |
| 81001 |
|
171 |
102 |
$0.00 |
| 88142 |
|
164 |
125 |
$0.00 |
| 90723 |
|
144 |
94 |
$0.00 |
| J3490 |
Unclassified drugs |
1,767 |
1,610 |
$0.00 |
| 0271 |
|
152 |
152 |
$0.00 |
| 0761 |
|
274 |
273 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
417 |
375 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
45 |
27 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
931 |
575 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
78 |
51 |
$0.00 |
| 85018 |
|
95 |
52 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
94 |
54 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
292 |
170 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14 |
12 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
208 |
140 |
$0.00 |
| 82728 |
|
138 |
83 |
$0.00 |
| 87625 |
|
45 |
27 |
$0.00 |
| 90698 |
|
87 |
38 |
$0.00 |
| 99381 |
|
86 |
62 |
$0.00 |
| 90632 |
|
105 |
105 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
221 |
117 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
12 |
12 |
$0.00 |
| 90744 |
|
50 |
24 |
$0.00 |
| 87081 |
|
24 |
13 |
$0.00 |
| 90688 |
|
53 |
16 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
17 |
12 |
$0.00 |
| 90381 |
|
26 |
16 |
$0.00 |
| 90651 |
|
16 |
13 |
$0.00 |
| 83721 |
|
1,032 |
654 |
$0.00 |
| 90750 |
|
308 |
212 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
103,386 |
55,731 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,496 |
1,497 |
$0.00 |
| 81002 |
|
4,019 |
1,694 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
727 |
503 |
$0.00 |
| 84450 |
|
139 |
87 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
11,878 |
6,354 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
2,188 |
1,351 |
$0.00 |
| 93017 |
|
1,207 |
1,127 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,346 |
966 |
$0.00 |
| 90715 |
|
432 |
278 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,564 |
2,163 |
$0.00 |
| 90649 |
|
312 |
176 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
42 |
25 |
$0.00 |
| 90670 |
|
990 |
485 |
$0.00 |
| 82274 |
|
796 |
780 |
$0.00 |
| 99188 |
|
455 |
259 |
$0.00 |
| 81025 |
|
180 |
115 |
$0.00 |
| 82947 |
|
81 |
51 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,131 |
650 |
$0.00 |
| 59425 |
|
183 |
109 |
$0.00 |
| 90671 |
|
137 |
92 |
$0.00 |
| 82465 |
|
450 |
286 |
$0.00 |
| 83718 |
|
450 |
286 |
$0.00 |
| 84295 |
|
101 |
66 |
$0.00 |
| 82565 |
|
138 |
86 |
$0.00 |
| 80076 |
|
52 |
27 |
$0.00 |
| 83540 |
|
119 |
71 |
$0.00 |
| 84460 |
|
148 |
92 |
$0.00 |
| 90633 |
|
344 |
162 |
$0.00 |
| Z6414 |
|
54 |
44 |
$0.00 |
| 87210 |
|
88 |
54 |
$0.00 |
| 84520 |
|
24 |
13 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| 90756 |
|
16 |
15 |
$0.00 |
| 83655 |
|
43 |
25 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
23 |
14 |
$0.00 |
| 90713 |
|
19 |
12 |
$0.00 |